CDC issues update on emerging multidrug-resistant yeast
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris, an emerging, multidrug-resistant yeast. CDC alerted health care facilities to the concern last year and provided an update this May. As of Aug. 31, 153 confirmed or probable cases of C. auris infection have been reported from 10 states, with most of the cases in New York and New Jersey. “The key to controlling its spread is rapidly identifying infected or colonized patients, and implementing effective infection control measures including hand hygiene, adherence to contact precautions, and performing thorough environmental disinfection,” CDC said.
Related News Articles
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
More than 704,000 people arrived alive at a hospital emergency department for treatment of a firearm-related injury between 2006 and 2014, resulting in an…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention this week launched Rx Awareness, a communications campaign to educate the public about the risks associated with…
Headline
An estimated 92% of hospital workers report receiving a flu vaccine for the 2016-17 flu season, compared with 76% of ambulatory care workers and 68% of long-…
Headline
More than 2 million cases of chlamydia, gonorrhea and syphilis were reported in the U.S. in 2016, a record high, according to the latest annual report by the…